SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-080239
Filing Date
2013-11-04
Accepted
2013-11-04 06:05:03
Documents
15
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-19698_110q.htm 10-Q 741152
2 EX-31.1 a13-19698_1ex31d1.htm EX-31.1 11578
3 EX-31.2 a13-19698_1ex31d2.htm EX-31.2 12451
4 EX-32.1 a13-19698_1ex32d1.htm EX-32.1 8061
11 GRAPHIC g196981gai001.gif GRAPHIC 11972
12 GRAPHIC g196981gai002.gif GRAPHIC 10505
13 GRAPHIC g196981gai003.jpg GRAPHIC 21630
14 GRAPHIC g196981gai004.jpg GRAPHIC 11326
15 GRAPHIC g196981gai005.jpg GRAPHIC 25685
  Complete submission text file 0001104659-13-080239.txt   5472140

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snta-20130930.xml EX-101.INS 627267
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snta-20130930.xsd EX-101.SCH 53246
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snta-20130930_cal.xml EX-101.CAL 42219
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT snta-20130930_lab.xml EX-101.LAB 825471
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snta-20130930_pre.xml EX-101.PRE 387611
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snta-20130930_def.xml EX-101.DEF 216609
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 131187501
SIC: 2834 Pharmaceutical Preparations